“ We are not interested in mass production products, rather focusing on niche generics where there are far more opportunities worldwide ”
In Conversation
“ As a Dane, I am very happy that Amgen has put a spotlight on Denmark, especially with the acquisitions that have been made over the last… ”
“ Having worked across Sweden, Norway, and Finland, I can say that, unfortunately, Denmark has become the most difficult Nordic market in which to launch new medications.… ”
“ Looking at Vision 2030, it is evident that the country's healthcare system is shifting to quality-based care which means that there will be improvements in efficiency,… ”
“ Having been used to battling against data separation and silos in the UK – where although the healthcare system is robust, the level of data integration… ”
“ The Saudi FDA and other authorities are advancing in the protection of innovation, helping not only to create better access to innovation, but also encouraging more… ”
“ Vision 2030 is creating greater stakeholder alignment, and making Saudi Arabia a more attractive destination for pharma industry investment, especially in clinical trials at this stage,… ”
“ All stakeholders want to maintain our leading position on access, which will perhaps require even closer collaboration with the Medicines Council and Amgros, making sure that… ”
“ There is a wealth of knowledge in Denmark, especially in the cardiometabolic area, and a strong culture of collaboration, to which we contribute and benefit from ”
“ Celltrion is a true pioneer in biosimilars. Our objective at the moment is to launch at least one product per year; we try to be very… ”
“ There is great potential for improvement if pharma companies can use agreed-upon standards for collecting data and for data interoperability ”
“ We could accelerate knowledge, save more children, and position drugs for more indications if we were able to conduct research [in Latin America] ”
